Still recall CSL was criticised by some fund managers for buying Seqirus. Look at it now. It has been a superb strategic fit for CSL. This company rarely put a foot wrong. That is why I will hold for the foreseeable future.
News: CSL Seqirus' Cell-Based QIVC Gets Positive Opinion From CHMP, page-2
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$300.58 |
Change
-1.210(0.40%) |
Mkt cap ! $145.5B | |||
| Open | High | Low | Value | Volume |
| $300.74 | $300.99 | $298.81 | $240.1M | 820.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $300.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $300.59 | 836 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |